Year: 2017
Type: review
Source: Blood
Authors: Jean Luc Harousseau, Michel Attal
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: relapsed multiple myeloma, first relapse, salvage therapy, lenalidomide-dexamethasone, bortezomib-dexamethasone, daratumumab, pomalidomide, carfilzomib, ixazomib, panobinostat, elotuzumab, lenalidomide resistance, bortezomib resistance, progression-free survival, treatment decision algorithm, autologous stem cell transplantation, drug costs
Open Access status: bronze
Funder: Agence Nationale de la Recherche
OpenAlex ID: W2731606591
